Amandeep Salhotra, MD
Enriched profileAssociate Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation · City of Hope
Amandeep Salhotra is Associate Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation at City of Hope. OpenAlex indexes 359 publications with 3,753 citations (h-index 30); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 10 Oct 2026
Overview
Updated 14 Oct 2026
Amandeep Salhotra, MD, is Associate Professor, Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation at City of Hope, Duarte, CA. The public record shows 359 publications with 3,753 citations (h-index 30), centered on Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · Leukemia & lymphoma
- Top research focus: Hematopoietic Stem Cell Transplantation
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 31 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 68.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
Sponsor: City of Hope Medical Center
- Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
Sponsor: City of Hope Medical Center
Industry payments
Updated 14 Oct 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year202552 payments$49,628openpaymentsdata.cms.gov ↗
- SANOFI US SERVICES INC.Program year20251 payment$16,820openpaymentsdata.cms.gov ↗
- SANOFI-AVENTIS U.S. LLCProgram year20259 payments$14,638openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.4%Kinase inhibitor14.6%Jakafi60%Iclusig27%Sirolimus13%Part D<11 patientsSelective immunosuppressants9.9%Rezurock100%Part D≥12 patients+ 2 more classes in this area
Anti-infectives
19.6%Short-acting sulfonamides4.7%Sulfamethoxazole-Trimethoprim100%Part D≥14 patientsAzole Antifungal3.6%Posaconazole100%Part D≥11 patients+ 6 more classes in this area
Cardiovascular
12.3%Statin4.5%Atorvastatin Calcium67%Pravastatin Sodium33%Part D<11 patientsBeta blocker2.8%Metoprolol Succinate100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Oct 2026
104 congress contributions (2016–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Abstract 5598: Exploiting electron transport chain dynamics to sensitize OXPHOS-dependent cancers to immunotherapy
AACR Annual Meeting
AACR2026Co-author - Allogeneic hematopoietic stem cell transplantation for acute leukemias of mixed or ambiguous lineage
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis.
Bone marrow transplantation
Article2026 - Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis.
Bone marrow transplantation
Letter2025 - Graft Versus Host Disease: Management Issues in the Intensive Care Unit.
Journal of intensive care medicine
Review2025 - The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.
British journal of haematology
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host DiseaseArticle194 citations2021
- 04Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host DiseaseArticle153 citations2024
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/amandeep-salhotra-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/amandeep-salhotra-96103a1a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
onclive.com/view/dr-amandeep-salhotra-on-the-efficacy-and-safety-of-orca-q-in-gvhd
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗
- MBBS
Maulana Azad Medical College, University of Delhi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗ - MD in Pediatrics
Maulana Azad Medical College, University of Delhi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hope Rugo, MD
City of Hope
Jana Portnow, MD
City of Hope
Amrita Krishnan, MD
City of Hope
James Ito, MD
City of Hope
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center